Home/ Supplements/ Feverfew/ Feverfew Extract

Feverfew Extract

product on market Tablet or Pill Source Naturals Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 17% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Feverfew leaf extract is supported by moderate evidence for reducing the frequency of migraine headaches. Vitamin C, calcium, and magnesium provide general nutritional support for immune function and neuromuscular health. Research coverage for this specific combination is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Feverfew Extract
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
50
Servings
Botanical with Nutrients
Product Type
17%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Total Carbohydrates
1 Gram(s) (1% DV)
Vitamin C
20 mg (33% DV)
Calcium
72 mg (7% DV)
140 mg (35% DV)
Within RDA (0.3× RDA) 316 studies (A:8, B:159)
Market median: 380.0mg (120 products) 8 studies — no high-quality reviews
100 mg
Market median: 380.0mg (120 products) 8 studies — no high-quality reviews

Other Ingredients

Sorbitol Stearic Acid modified Cellulose Gum Silica
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: 1 or 2 tablets daily between meals.

Warnings & Precautions

Note: If you are pregnant, may become pregnant, or breastfeeding, consult your health care professional before using this product.

Do not use if either tamper-evident seal is broken or missing.

Keep out of the reach of children.

Formulation Notes

Feverfew (Tanacetum parthenium) is a member of the daisy family. Its extract has been shown in human cell culture studies to inhibit the synthesis of prostaglandins known to cause physical discomfort. Further research needs to be conducted to confirm its effects, if any, in humans.

Metadata

Product Details

UPC / SKU0 21078 00209 3
DSLD Entry Date2019-12-22
Product TypeBotanical with Nutrients
FormTablet or Pill
DSLD ID211659
Data Updated2026-04-11
Research

Research Evidence

10
Research Sources
48
Avg Quality
4
Systematic Review
4
Rct
1
Meta Analysis
1
Cochrane Review
B Feverfew for preventing migraine.
Cochrane Review The Cochrane database of systematic reviews PubMed
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2004 PubMed
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2000 PubMed
C Randomised double-blind placebo-controlled trial of feverfew in migraine prevention
Rct Lancet (London, England) 1988 PubMed
C Feverfew for migraine prophylaxis: a systematic review
Systematic Review Journal of dietary supplements 2009 PubMed DOI
C Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study
Meta Analysis Clinical drug investigation 2006 PubMed
C The combined effect of acupuncture and Tanacetum parthenium on quality of life in women with headache: randomised study
Rct Acupuncture in medicine : journal of the British Medical Acupuncture Society 2012 PubMed DOI
C A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial
Rct Headache 2004 PubMed
C Feverfew as a preventive treatment for migraine: a systematic review
Systematic Review Cephalalgia : an international journal of headache 1998 PubMed
D Efficacy of feverfew as prophylactic treatment of migraine
Rct British medical journal (Clinical research ed.) 1985 PubMed
View all evidence for Feverfew →
Compare

Similar Products

View all Feverfew products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.